Compare JSPR & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JSPR | SNAL |
|---|---|---|
| Founded | 2018 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 21.2M |
| IPO Year | 2019 | 2022 |
| Metric | JSPR | SNAL |
|---|---|---|
| Price | $14.35 | $2.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 321.1K | 124.1K |
| Earning Date | 11-27-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 19.22 | ★ 120.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $81,225,622.00 |
| Revenue This Year | N/A | $22.50 |
| Revenue Next Year | N/A | $9.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.32 | $0.59 |
| 52 Week High | $17.03 | $21.60 |
| Indicator | JSPR | SNAL |
|---|---|---|
| Relative Strength Index (RSI) | 80.68 | 45.40 |
| Support Level | $0.64 | $1.92 |
| Resistance Level | $17.03 | $2.63 |
| Average True Range (ATR) | 1.05 | 0.27 |
| MACD | 1.15 | 0.04 |
| Stochastic Oscillator | 79.63 | 23.36 |
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States. The Company has one operating and reportable segment. The company operates in the USA, the UK and Other Countries.